- Nano-X Imaging Ltd. is set to release its crucial quarterly earnings report on August 11, 2026, offering insights into its financial health and future prospects.
- Analysts anticipate a net loss for the medical imaging company, with a consensus EPS of -$0.16 and a negative P/E ratio, reflecting its current unprofitability.
- The earnings release date coincides with the deadline for a significant securities class action lawsuit against Nano-X Imaging Ltd., adding to investor scrutiny and market trends.
Nano-X Imaging Ltd. (NASDAQ: NNOX) is a medical imaging company focused on developing a new type of X-ray source. The company is approaching a key date, August 11, 2026, when it will release its quarterly earnings report. This report will give investors a fresh look at the company’s financial health and progress in the medical technology sector.
Wall Street analysts are anticipating the company will report a loss. The consensus estimate for Nano-X Imaging Ltd.’s earnings per share (EPS) is -$0.16. EPS is a measure of a company’s profit divided by its number of stock shares. A negative EPS means the company lost money during the quarter, impacting its investor outlook and overall financial performance.
The revenue forecast for the quarter is about $5.39 million. This expectation aligns with the company’s recent financial performance, which shows it is not yet profitable. This is reflected in its negative price-to-earnings (P/E) ratio of -0.93. A negative P/E ratio occurs when a company has negative earnings, a key metric for stock analysis.
The company’s financial data also shows a negative earnings yield of -1.03 and a negative enterprise value to operating cash flow ratio of -0.83. This indicates challenges in generating positive cash from its main business activities. On a positive note, Nano-X Imaging Ltd. has a low debt-to-equity ratio of 0.06, which can be a positive sign for long-term stability.
The earnings release date is also the deadline for a securities class action lawsuit, as highlighted by law firms Faruqi & Faruqi, LLP and the Rosen Law Firm. The lawsuit is for investors who bought Nano-X Imaging Ltd. securities between March 31, 2025, and April 17, 2026, and experienced losses, adding another layer of scrutiny to the upcoming quarterly results.
